← Back to all trials
Terminated
NCT06094387
The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients
Conditions: Central Line Complication, Thrombosis, Venous
Sex: All
Ages: 18 Years – 100 Years
Healthy volunteers: No
Enrollment: 2
Sponsor: Queen Mary Hospital, Hong Kong
Location: Queen Mary Hospital Hong Kong
Summary
To study thrombin generation parameters in critically ill patients with and without central line related thrombosis (CRT).
Eligibility Criteria
Inclusion Criteria:
* Age ≧ 18; AND
* Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital in Hong Kong; AND
* Clinically indicated for central catheter insertion, which includes central venous catheters and dialysis catheters; AND
* Expected to have the central catheter in place for at least 5 days in their ICU stay.
Exclusion Criteria:
* Patients known to have active venous thromboembolism including deep venous thrombosis or pulmonary embolism;
* Patients known to have hypercoagulable states, e.g., hereditary thrombophilia, antiphospholipid syndrome; OR
* Patients with active solid organ or hematological malignancies; OR
* Patients already receiving therapeutic anticoagulation prior to study recruitment; OR
* Patients with thrombosis detected in the insertion site before central catheter insertion; OR
* Patients with a central venous catheter already in place prior to ICU admission; OR
* Patients admitted to the ICU for post-operative care; OR
* Patients admitted to the ICU for trauma care; OR
* Patients requiring extra-corporeal life support (ECLS); OR
* Patients with poor window or inaccessible for ultrasonographic examination; OR
* Pregnancy/post-partum within 6 weeks
Source: ClinicalTrials.gov (NCT06094387). StuddyBuddy aggregates publicly available trial information.